Aiko Murai

839 total citations
35 papers, 433 citations indexed

About

Aiko Murai is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Aiko Murai has authored 35 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Aiko Murai's work include Immunotherapy and Immune Responses (14 papers), Cancer Cells and Metastasis (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Aiko Murai is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Cells and Metastasis (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Aiko Murai collaborates with scholars based in Japan. Aiko Murai's co-authors include Toshihiko Torigoe, Yoshihiko Hirohashi, Tomohide Tsukahara, Takayuki Kanaseki, Noriyuki Sato, Terufumi Kubo, Shinsuke Araki, Toshiyuki Nomura, Munehide Nakatsugawa and Risa Miyashita and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Aiko Murai

32 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aiko Murai Japan	11	301	132	93	71	56	35	433
Rashid Gabbasov United States	10	286 1.0×	158 1.2×	91 1.0×	60 0.8×	56 1.0×	21	525
Tracy J. Berg United States	10	279 0.9×	125 0.9×	72 0.8×	111 1.6×	77 1.4×	15	461
Kevin O’Hayer United States	10	315 1.0×	263 2.0×	113 1.2×	88 1.2×	75 1.3×	18	568
Olivia Lanvin France	12	246 0.8×	101 0.8×	73 0.8×	68 1.0×	34 0.6×	14	420
Maria Pozzuto United States	5	166 0.6×	154 1.2×	73 0.8×	74 1.0×	83 1.5×	5	322
Alexander Schulz Germany	9	257 0.9×	181 1.4×	51 0.5×	98 1.4×	23 0.4×	13	419
Yuliya Petrova United States	7	269 0.9×	110 0.8×	43 0.5×	62 0.9×	112 2.0×	9	415
Avital Lev United States	11	215 0.7×	182 1.4×	43 0.5×	110 1.5×	51 0.9×	20	386
Alessandro Carugo United States	11	225 0.7×	153 1.2×	44 0.5×	115 1.6×	30 0.5×	17	362
Jianhua Chen China	15	376 1.2×	132 1.0×	81 0.9×	116 1.6×	54 1.0×	33	630

Countries citing papers authored by Aiko Murai

Since Specialization

Citations

This map shows the geographic impact of Aiko Murai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiko Murai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiko Murai more than expected).

Fields of papers citing papers by Aiko Murai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiko Murai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiko Murai. The network helps show where Aiko Murai may publish in the future.

Co-authorship network of co-authors of Aiko Murai

This figure shows the co-authorship network connecting the top 25 collaborators of Aiko Murai. A scholar is included among the top collaborators of Aiko Murai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiko Murai. Aiko Murai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murai, Aiko, et al.. (2025). CXCR5-targeted chimeric antigen receptor T regulatory cells for the selective inhibition of follicular helper T cell and B cell interaction. Cytotherapy. 27(5). 571–580. 1 indexed citations

Sasaki, Kenta, Hiroki Kobayashi, Munehide Nakatsugawa, et al.. (2025). MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells. Biochemistry and Biophysics Reports. 41. 101946–101946. 1 indexed citations

Kawai, Noriko, Aiko Murai, Serina Tokita, et al.. (2025). The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma. Scientific Reports. 15(1). 26638–26638.

Murata, Kenji, Yuka Mizue, Aiko Murai, et al.. (2024). Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment. Science Translational Medicine. 16(776). eadk8832–eadk8832. 8 indexed citations

Murai, Aiko, Yuka Mizue, Terufumi Kubo, et al.. (2024). Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes. Cancer Genomics & Proteomics. 21(4). 414–420. 1 indexed citations

Hirohashi, Yoshihiko, Goro Kutomi, Kenji Murata, et al.. (2023). Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5. Cancer Science. 114(12). 4511–4520. 5 indexed citations

Hirohashi, Yoshihiko, Rena Morita, Akihiro Miyazaki, et al.. (2023). Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy. Cancer Science. 114(9). 3496–3508. 4 indexed citations

Sasaki, Kenta, Yoshihiko Hirohashi, Kenji Murata, et al.. (2023). SOX10 Inhibits T Cell Recognition by Inducing Expression of the Immune Checkpoint Molecule PD-L1 in A375 Melanoma Cells. Anticancer Research. 43(4). 1477–1484. 7 indexed citations

Hirohashi, Yoshihiko, Munehide Nakatsugawa, Aiko Murai, et al.. (2021). Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 71(4). 905–918. 9 indexed citations

10.

Murai, Aiko, Shunsuke Ebara, Satoshi Sasaki, et al.. (2020). Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors. PLoS ONE. 15(10). e0240718–e0240718. 15 indexed citations

11.

Tsukahara, Tomohide, Kazue Watanabe, Kenji Murata, et al.. (2019). Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma. Cancer Immunology Immunotherapy. 69(2). 189–197. 4 indexed citations

12.

Kawai, Noriko, Yoshihiko Hirohashi, Yuma Ebihara, et al.. (2019). ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD. PLoS ONE. 14(5). e0216503–e0216503. 34 indexed citations

13.

Hirohashi, Yoshihiko, Shinichi Hashimoto, Tasuku Mariya, et al.. (2018). Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma. Experimental and Molecular Pathology. 106. 78–88. 6 indexed citations

14.

Shima, Hiroaki, Goro Kutomi, Masafumi Imamura, et al.. (2018). Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine. Cancer Immunology Immunotherapy. 67(10). 1603–1609. 6 indexed citations

15.

Hirohashi, Yoshihiko, Hiroshi Kitamura, Sachiyo Nishida, et al.. (2017). GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis. Oncotarget. 8(17). 28826–28839. 14 indexed citations

16.

Hirohashi, Yoshihiko, Min Shen, Liming Wang, et al.. (2017). Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells. Biochemical and Biophysical Research Communications. 485(3). 651–657. 18 indexed citations

17.

Wang, Liming, Yoshihiko Hirohashi, Tadashi Ogawa, et al.. (2017). LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells. Biochemical and Biophysical Research Communications. 486(2). 232–238. 9 indexed citations

18.

Hirohashi, Yoshihiko, Aiko Murai, Rena Morita, et al.. (2016). Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480. PLoS ONE. 11(7). e0158903–e0158903. 9 indexed citations

19.

Kamiguchi, Kenjiro, Yoshihiko Hirohashi, Yasuaki Tamura, et al.. (2016). A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner. Biochemical and Biophysical Research Communications. 474(4). 626–633. 21 indexed citations

20.

Tsushima, Kazunori, et al.. (1995). CONVERSION OF N-ACYLLACTAMS INTO ALPHA -ALKYLATED CYCLIC ENAMIDES VIA VINYL TRIFLATES. Chemistry Letters. 1995(9). 801–802. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact